FDA to Hold Public Meeting on Balancing Innovation and Access to Prescription Drugs

Summary

The Food and Drug Administration (FDA) is hosting a public meeting to discuss the administration of the Hatch-Waxman Amendments, which aim to strike a balance between encouraging innovation in drug development and making lower-cost alternatives available to the public.